Treatment with the investigational single-agent belantamab mafodotin resulted in a 31% overall response rate with the 2.5 mg/kg regimen in patients with heavily pre-treated multiple myeloma.
FDA Jan. 2 issued a final guidance that will restrict the sale of e-cigarette flavors most popular with minors.
HHS Dec. 18 announced a plan to allow states, drug wholesalers and pharmacies to import cheaper drugs from Canada.
Everett E. Vokes was elected president of the American Society of Clinical Oncology for the 2021-22 term.
Stephen M. Hahn was sworn as Commissioner of FDA Dec. 17.
Fred Hutchinson Cancer Research Center received a five-year, $13 million NCI SPORE grant in August to improve cancer outcomes.
The Department of Neurosurgery at the Icahn School of Medicine at Mount Sinai has received more than $10 million in federal funding for several projects focusing on brain tumor research.
Ten oncology practices in the United States received grant funding from the American Society of Clinical Oncology to participate in the society's Quality Oncology Practice Initiative and Quality Training Program.
PharmaMar and Jazz Pharmaceuticals Ireland Ltd. have entered into an exclusive license agreement for lurbinectedin in the United States.
Thomas Jefferson University and Temple University Dec. 18 entered into a binding definitive agreement for Jefferson's acquisition of Fox Chase Cancer Center and Temple's Bone Marrow Transplant Program.
